Prostaglandin E1 improved the function of transplanter fatty liver in a rat reduced-size-liver transplantation model under conditions of permissible cold preservation

Liver Transplantation

Volumn 9, Issue 1, 2003, Pages 79-86

  Morioka, Daisuke ^a   Kubota, Toru ^a   Sekido, Hitoshi ^a   Matsuo, Kenichi ^a   Saito, Shuji ^a   Ichikawa, Yasuschi ^a   Endo, Itaru ^a   Togo, Shinji ^a   Shimada, Hiroshi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HYALURONIC ACID; PROSTAGLANDIN E1; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CRYOPRESERVATION; EXPERIMENTAL MODEL; FATTY LIVER; GRAFT SURVIVAL; LIVER FUNCTION; LIVER GRAFT; LIVER ISCHEMIA; LIVER SIZE; LIVER TRANSPLANTATION; LIVER WEIGHT; MALE; NONHUMAN; ORGAN DONOR; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RAT; RAT STRAIN; REPERFUSION INJURY; TREATMENT OUTCOME;

EID: 0037235108     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2003.36845     Document Type: Article

References (51)

1. Urena MAG, Moreno Gonzalez E, Romero CJ, Ruiz-Delgado FC, Moreno Sanz C. An approach to the rational use of steatotic donor livers in liver transplantation. Hepatogastroenterol 1999; 46:1164-1173.
2. Todo S, Demetris AJ, Makowka L, Teperman L, Podesta L, Shaver T, et al. Primary nonfunction of hepatic allografts with preexisting fatty infiltration. Transplantation 1989;47:903-905.
3. Adam R, Reynes M, Johann M, Morino M, Astarcioglu I, Kafetzis I, et al. The outcome of steatotic grafts in liver transplantation. Transplant Proc 1991;23:1538-1540.
4. D'Alessandro AM, Kalayoglu M, Sollinger HW, Hoffmann RM, Reed A, Knechtle SJ, et al. The predictive value of donor liver biopsies for the development of primary non function after orthotopic liver transplantation. Transplantation 1991;51:157-163.
5. Hayashi M, Tokunaga Y, Fujita T, Tanaka K, Yamaoka Y, Ozawa K. The effects of cold preservation on steatotic graft viability in rat liver transplantation. Transplantation 1993;56: 282-287.
6. Husberg BS, Genyk YS, Klintmalm GB. A new rat model for studies of the ischemic injury after transplantation of fatty livers: Improvement after postoperative administration of prostaglandin. Transplantation 1994;57:457-458.
7. Kawasaki S, Makuuchi M, Matsunami H, Hashikura Y, Ikegami T, Nakazawa Y, et al. Living related liver transplantation in adults. Ann Surg 1998;227:269-274.
8. Kawasaki S, Makuuchi M, Matsunami H, Hashikura Y, Ikegami T, Nakazawa Y, et al. Living related liver transplantation: A wider application. Transplant Proc 1995;27:1170-1172.
9. Kawasaki S, Makuuchi M, Ishizone S, Matsunami H, Terada M, Kawarazaki H. Liver regeneration in recipients and donors after transplantation. Lancet 1992;339:580-581.
10. Kubota T, Takabe K, Yang M, Sekido H, Endo I, Ichikawa Y, et al. Minimum sizes for remnant and transplanted livers in rats. J Hep Bil Pancr Surg 1997;4:398-404.
11. Kamada N, Calne RY. A surgical experience with five hundred thirty liver transplants in the rat. Surgery 1983;93:64-69.
12. Natori S, Fujii Y, Kurosawa H, Nakano A, Shimada H. Prostaglandin E1 protects against ischemia-reperfusion injury of the liver by inhibition of neutrophil adherence to endothelial cells. Transplantation 1997;64:1514-1520.
13. Lou J, Buhler L, Deng S, Mentha G, Montesano R, Grau GE, Morel P. Inhibition of leukocyte adherence and transendothelial migration in cultured human liver vascular endothelial cells by prostaglandin E1. Hepatology 1998;27:822-828.
14. Iwata K, Shimazu M, Wakabayashi G, Ohshima A, Yoshida M, Kitajima M. Intraportal perfusion of prostaglandin E1 attenuates hepatic postischemic microcirculatory impairments in rats. J Gastroenterol Hepatol 1999;14:634-641.
15. Shirabe K, Kin S, Shinagawa Y, Chen S, Payne WD, Sugimachi K. Inhibition of thromboxane A2 activity during warm ischemia of the liver. J Surg Res 1996;61:103-107.
16. Itasaka H, Suehiro T, Wakiyama S, Yanaga K, Shimada M, Sugimachi K. The mechanism of hepatic graft protection against reperfusion injury by prostaglandin E1. Jpn J Surg 1999;29:526-532.
17. Masaki N, Ohta Y, Shirataki H, Ogata I, Hayashi S, Yamada S, et al. Hepatocyte membrane stabilization by prostaglandin E1 and E2: Favorable effects on rat liver injury. Gastroenterology 1992; 102:572-576.
18. Hanazaki K, Kuroda T, Kajikawa S, Shinohara E, Haba Y, Iida F. Prostaglandin E1 protects liver from ischemic damage. J Surg Res 1994;57:380-384.
19. Ueda Y, Matsuo K, Kamei T, Kayashima K, Konomi K. Protective effect of prostaglandin E1 (PGE1) on energy metabolism and reticuloendothelial function in the ischemically damaged canine liver. Liver 1989;9:6-13.
20. Kurosawa H, Shimada H, Nakano A, Natori S, Fujii Y. The role of intracellular calcium in the production of superoxide anion by Kuppfer cells stimulated by lipopolysaccharide and the efficacy of prostaglandin E1. Int Hepatol Com 1996;4:326-333.
21. Sikujara O, Monden M, Toyoshima K, Okamura J, Kosaki G. Cytoprotective effect of prostaglandin I2 on ischemia-induced hepatic cell injury. Transplantation 1983;36:238-243.
22. Kishimoto S, Sakon M, Umeshita K, Miyoshi H, Taniguchi K, Meng W, et al. The inhibitory effect of prostaglandin E1 on oxidative stress-induced hepatocyte injury evaluated by calpain-μ activation. Transplantation 2000;69:2314-2319.
23. Parry GC, Mackman N. Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-κB-mediated transcription. J Immunol 1997;159:5450.
24. Haraguchi S, Good RA, Day NK. Immunosuppressive retroviral peptides: cAMP and cytokine patterns. Immunol Today 1995; 16:595.
25. Perrot MD, Fischer S, Liu M, Jin R, Bai X-H, Waddell TK, Keshavjee S. Prostaglandin E1 protects lung transplants from ischemia-reperfusion injury: A shift from pro- to anti-inflammatory cytokines. Transplantation 2001;72:1505-1512.
26. Takahashi K, Yamamoto N, Egawa H, Takeuchi T, Yamaguchi T, Takada Y, et al. Effect of prostaglandin E1 on preservation injury of canine liver grafts preserved in UW solution. Transplant Int 1993;6:245-250.
27. Cywes R, Harvey PRC, Packham MA, Cameron R, Strasberg SM. The influence of prostaglandin E1 on platelet adherence and injury in preserved rat liver allografts. Liver Transplant Surg 1996;2:23-36.
28. Sakr MF, Zetti GM, Hassanein TI, Farghali H, Nalesnik MA, Gavaler JS, et al. FK506 ameliorates the hepatic injury associated with ischemia and reperfusion in rats. Hepatology 1991;13:947-951.
29. Dhar K, Nagasue N, Kimoto T, Uchida M, Takemoto Y, Nakamura T. The salutary effect of FK506 in ischemia-reperfusion injury of the canine liver. Transplantation 1992;54:583-588.
30. Sakr MF, McClain CJ, Gavaler JS, Tetti GM, Starzl TE, Van Thiel DH. FK506 pre-treatment is associated with reduced levels of tumor necrosis factor and interleukin 6 following hepatic ischemia/reperfusion. J Hepatol 1993;17:301-307.
31. Suzuki S, Toledo-Peleyra LH, Rodriguez FJ, Cejalvo D. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine. Transplantation 1993;55:1265-1272.
32. Suzuki S, Toledo-Pereyra LH. Interleukin 1 and tumor necrosis factor production as the initial stimulates pf liver ischemia and reperfusion injury. J Surg Res 1994;57:253-258.
33. Dhar DK, Teramoto Y, Nagasue N, Uchida M, Ono T, Nakamura T. FK506 maintains cellular calcium homeostasis in ischemia-reperfusion injury of the canine liver. J Surg Res 1996;60: 142-146.
34. Garcia-Criado FJ, Palma-Vargas JM, Valdunciel-Garcia JJ, Toledo AH, Misawa K, Gomez-Alonzo A, et al. Tacrolimus (FK506) down-regulates free radical tissue levels, serum cytokines, and neutrophil infiltration after severe liver ischemia. Transplantation 1997;64:594-598.
35. Matsuda T, Yamaguchi Y, Matsumura F, Akizuki E, Okabe K, Lian J, et al. Immunosuppressants decrease neutrophil chemoattractantand attenuate ischemia/reperfusion injury of the liver in rats. J Trauma 1998;44:475-484.
36. Kaibori M, Inoue T, Tu W, Oda M, Kwon AH, Kamiyama Y, et al. FK506, but not cyclosporin A, prevents mitochondrial dysfunction during hypoxia in rat hepatocytes. Life Sci 2001;69:17-26.
37. Hui A-M, Kawasaki S, Makuuchi M, Nakayama J, Ikegami T, Miyagiwa S. Liver injury following normothermic ischemia in steatotic rat liver. Hepatology 1994;20:1287-1293.
38. Koneru B, Reddy M, Torre A, Patel D, Ippolito T, Ferrante RJ. Studies of hepatic warm ischemia in the obese Zucker rat. Transplantation 1995;59:942-946.
39. Nardo B, Domenicali M, Caraceni P, Dall'Agata M, Mazziotti A, Bernardi M, Cavallari A. Ischemia-reperfusion injury in the diet-induced rat fatty liver. Transplant Proc 1998;30:2317.
40. Rashid A, Wu T-C, Huang C-C, Chen C-H, Lin HZ, Yang SQ, et al. Mitochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver. Hepatology 1999;29:1131-1138.
41. Caraceni P, Nardo B, Dmenicali M, Turi P, Vici M, Simoncini M, et al. Ischemia-reperfusion injury in the rat fatty liver: Role of nutritional status. Hepatology 1999;29:1139-1146.
42. Hakamada K, Sasaki M, Takahashi K, Umehara Y, Konn M. Sinusoidal flow block after warm ischemia in rats with diet-induced fatty liver. J Surg Res 1997;70:12-20.
43. Ohara K. Study of microcirculatory changes in experimental dietary fatty liver. Hokkaido Igaku Zasshi 1989;64:177-185.
44. Day C, James O. Hepatic steatosis: Innocent bystander or guilty party? Hepatology 1998;27:1463-1466.
45. Fromenty B, Pessayre D. Impaired mitochondrial function in microvesicular steatosis. J Hepatol 1997;26:43-53.
46. Fukumori T, Ohkohchi N, Tsukamoto S, Satomi S. The mechanism of injury in a steatotic liver graft during cold preservation. Transplantation 1999;67:195-200.
47. Fukumori T, Ohkohchi N, Tsukamoto S, Satomi S. Why is a liver with steatosis susceptible to cold ischemic injury? Transplant Proc 1999;31:548-549.
48. Carles J, Fawaz R, Neaud V, Hamoudi NE, Bernard PH, Balabaud BSP. Ultrastructure of human liver grafts preserved with UW solution: Comparison between patients with low and high postoperative transaminases levels. J Submicrosc Cytol Pathol 1994;26:67-73.
49. Hatsugai K, Ohkohchi N, Fukumori T, Akamatsu Y, Satomi S. Mechanism of primary non-function in a rat model for fatty liver transplantation. Transplant Int 2000;13:583-590.
50. Seifalian AM, Piasecki C, Agarwal A, Davidson BR. The effect of graded steatosis on flow in the hepatic parenchymal microcirculation. Transplantation 1999;68:780-784.
51. Sun C-K, Zhang X-Y, Zimmermann A, Davis G, Wheatley AM. Effect of ischemia-reperfusion injury on the microcirculation of the steatotic liver of the Zucker rat. Transplantation 2001;72: 1625-1631.